Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1D | P28221 | 19/20 | 0.69 |
| ▸ | HTR1B | P28222 | 19/20 | 0.69 |
| ▸ | HTR1A | P08908 | 18/20 | 0.69 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.50 |
| ▸ | DRD2 | P14416 | 1/20 | 0.50 |
| ▸ | HTR2A | P28223 | 1/20 | 0.50 |
| ▸ | HTR1E | P28566 | 1/20 | 0.50 |
| ▸ | HTR1F | P30939 | 1/20 | 0.50 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.50 |
| ▸ | HTR7 | P34969 | 1/20 | 0.50 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.50 |
| ▸ | HTR2B | P41595 | 1/20 | 0.50 |
| ▸ | HTR5A | P47898 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5210070 | 0.91 | HTR1D (0.71) | HTR1DHTR1BHTR1AADRB2DRD2 | |
| SCHEMBL5210839 | 0.88 | HTR1D (0.68) | HTR1DHTR1BHTR1AADRB2DRD2 | |
| SCHEMBL5208628 | 0.85 | HTR1D (0.67) | HTR1DHTR1BHTR1AADRB2DRD2 | |
| SCHEMBL6392275 | 0.84 | HTR1D (0.55) | HTR1DHTR1BHTR1A | |
| SCHEMBL6399051 | 0.84 | HTR1D (0.53) | HTR1DHTR1BHTR1A | |
| SCHEMBL6392324 | 0.83 | HTR1D (0.57) | HTR1DHTR1BHTR1AADRB2DRD2 | |
| SCHEMBL6630036 | 0.82 | HTR1D (0.53) | HTR1DHTR1BHTR1A | |
| SCHEMBL5209392 | 0.82 | HTR1A (1.00) | HTR1DHTR1BHTR1AADRB2DRD2 | |
| SCHEMBL6648620 | 0.81 | HTR1D (0.57) | HTR1DHTR1BHTR1AADRB2DRD2 | |
| SCHEMBL5209481 | 0.81 | HTR1D (0.57) | HTR1DHTR1BHTR1AADRB2DRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1480972-B1 | COMPOUNDS POSSESSING AFFINITY AT 5HT1-TYPE RECEPTORS AND USE THEREOF IN THERAPY OF CNS DISORDERS | GLAXO GROUP LTD (GB) | 2007-04-11 | — | — | EP | disclosed |